Early cytomegalovirus reactivation is associated with a poorer outcome after an alemtuzumab-based reduced-intensity conditioning allogeneic stem cell transplant

被引：0
|
作者：
Noriega, V. [1 ]
Cutino-Moguel, T. [1 ]
Zuckerman, M. [1 ]
Potter, V. [1 ]
Barabino, L. [1 ]
Raj, K. [1 ]
McLornan, D. [1 ]
de Lavallade, H. [1 ]
Devereux, S. [1 ]
Marsh, J. [1 ]
Sudhanva, M. [1 ]
Mufti, G. [1 ]
Pagliuca, A. [1 ]
机构：
[1] Kings Coll Hosp, London, England
来源：
BONE MARROW TRANSPLANTATION | 2013年 / 48卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S299 / S300
页数：2
相关论文
共 50 条
  • [21] Cytomegalovirus Reactivation After Matched Sibling Donor Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplant Correlates With Donor Killer Immunoglobulin-like Receptor Genotype
    Sobecks, Ronald M.
    Askar, Medhat
    Thomas, Dawn
    Rybicki, Lisa
    Kalaycio, Matt
    Dean, Robert
    Avery, Robin
    Mossad, Sherif
    Copelan, Edward
    Bolwell, Brian J.
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2011, 9 (01) : 7 - 13
  • [22] Improved outcome following reduced-intensity conditioning for second allogeneic stem cell transplantation
    Nachbaur, D.
    Auberger, J.
    Clausen, J.
    Lindner, B.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S285 - S286
  • [23] Second Malignancies after Allogeneic Stem Cell Transplantation with Reduced-Intensity Conditioning: Is the Incidence Reduced?
    Shimoni, Avichai
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (11) : 1669 - 1670
  • [24] Incidence and Dynamics of Epstein-Barr Virus Reactivation After Alemtuzumab-Based Conditioning for Allogeneic Hematopoietic Stem-Cell Transplantation
    Carpenter, Ben
    Haque, Tanzina
    Dimopoulou, Maria
    Atkinson, Claire
    Roughton, Michael
    Grace, Sarah
    Denovan, Shari
    Fielding, Adele
    Kottaridis, Panagiotis D.
    Griffiths, Paul
    Mackinnon, Stephen
    Emery, Vincent
    Chakraverty, Ronjon
    TRANSPLANTATION, 2010, 90 (05) : 564 - 570
  • [25] Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis
    Nagi, W.
    Lim, Z. Y.
    Krishnamurthy, P.
    Potter, V.
    Tindell, V.
    Reiff-Zall, L.
    Abdullah, A.
    Lea, N.
    Kenyon, M.
    Marsh, J.
    Ho, A. Y. L.
    Mufti, G. J.
    Pagliuca, A.
    LEUKEMIA RESEARCH, 2011, 35 (08) : 998 - 1000
  • [26] Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant
    El-Cheikh, Jean
    Castagna, Luca
    Wang, Ling
    Esterni, Benjamin
    Faucher, Catherine
    Fuerst, Sabine
    Pierre, Berger
    Mohty, Mohamad
    Blaise, Didier
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1705 - 1710
  • [27] Influence of plasmacytoid dendritic cells recovery on outcome after reduced-intensity conditioning allogeneic stem cell transplantation
    Mohty, M
    Blaise, D
    Faucher, C
    Gastaut, JA
    Viens, P
    Olive, D
    Gaugler, B
    BONE MARROW TRANSPLANTATION, 2005, 35 : S45 - S45
  • [28] Impact of donor lymphocyte infusion on outcome after reduced-intensity conditioning allogeneic haematopoietic stem cell transplantation
    Michallet, M
    Mohty, M
    Le, QH
    Michallet, AS
    Faucher, C
    Thiebaut, A
    Tavernier, E
    Raffi, H
    Revesz, D
    Troncy, J
    Praire, A
    Gadolet, E
    Raus, N
    Dubois, V
    Gebuhrer, L
    Hequet, O
    Bourgeot, JC
    Nicolini, F
    BONE MARROW TRANSPLANTATION, 2005, 35 : S204 - S205
  • [29] Allogeneic myeloablative stem cell transplant as salvage therapy of reduced-intensity conditioned stem cell transplant: toxicity and outcome
    Cordonnier, C
    Hamladji, R
    Gratwohl, A
    Ljungman, P
    Martino, R
    Bordigoni, P
    Francois, S
    Deconninck, E
    Buzyn, A
    Bay, J
    Fouillard, L
    Kuentz, M
    BONE MARROW TRANSPLANTATION, 2006, 37 : S195 - S195
  • [30] Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse after an initial allogeneic transplant
    Shaw, B.
    Mufti, G. J.
    Mackinnon, S.
    Cavenagh, J.
    Towlson, K.
    Pearce, R.
    Pagliuca, A.
    Apperley, J.
    Craddock, C.
    Kazmi, M. A.
    Littlewood, T.
    Milligan, D.
    Thomson, K.
    Marks, D.
    Russell, N.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S16 - S16
12345